Cargando…
DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology
Prostate cancer (PCa) has a distinct molecular signature, including characteristic chromosomal translocations, gene deletions and defective DNA damage repair mechanisms. One crucial pathway involved is homologous recombination deficiency (HRD) and it is found in almost 20% of metastatic castrate-res...
Autores principales: | Grypari, Ioanna-Maria, Tzelepi, Vasiliki, Gyftopoulos, Kostis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380086/ https://www.ncbi.nlm.nih.gov/pubmed/37511177 http://dx.doi.org/10.3390/ijms241411418 |
Ejemplares similares
-
Radical or Not-So-Radical Prostatectomy: Do Surgical Margins Matter?
por: Grypari, Ioanna Maria, et al.
Publicado: (2021) -
Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma
por: Tzelepi, Vasiliki, et al.
Publicado: (2021) -
The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progression
por: Grypari, Ioanna Maria, et al.
Publicado: (2021) -
The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma
por: Papanikolaou, Sophia, et al.
Publicado: (2017) -
Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)